When you're trying to save money on prescription drugs, you might have heard about authorized generics. These aren't your typical generics. They're made by the same company that makes the brand-name drug, but sold under a different label - often at a lower price. The problem? Finding accurate, up-to-date information on which ones exist and where to get them isn't always easy. The U.S. Food and Drug Administration (FDA) keeps the official list, but it's not as straightforward as searching Google.
What Exactly Is an Authorized Generic?
An authorized generic is the exact same drug as the brand-name version - same active ingredients, same dose, same shape, same way it works in your body. The only difference? It doesn't carry the brand name on the label. It might look different - maybe a different color or marking - but it's chemically identical. These are not made by a separate generic company. They're produced by the original brand manufacturer, often under a different label, and sold at a lower price point.
Here's why that matters: when a brand-name drug's patent is about to expire, other companies can apply to make generic versions. But the brand company can also launch its own generic version - an authorized generic - before the first generic even hits the market. This can slow down price drops because consumers now have two options: the brand name or the brand's own cheaper version. The FDA tracks these because they're not listed in the Orange Book, which is where most people look for generics.
Where to Find the Official FDA List
The FDA maintains the only official public list of authorized generics. You won't find them in the Orange Book. You won't find them in Drugs@FDA. The list lives on a specific page: fda.gov/drugs/abbreviated-new-drug-application-anda/fda-list-authorized-generic-drugs.
This page includes a downloadable PDF that updates every three months. The most recent version as of October 10, 2025, contains over 850 entries. Each entry lists:
- The brand name (e.g., ACTIQ, ARTHROTEC, CLEOCIN T)
- The dosage form and strength (e.g., 1200 mcg lozenge, 50 mg/200 mcg tablet)
- The name of the brand manufacturer (e.g., Cephalon, LLC; Pfizer Inc.)
- The date the authorized generic entered the market (based on annual reports, not exact launch dates)
The file is about 1.09 MB - large enough to be useful, but not searchable like a website. You have to download it, open it in Adobe Reader or another PDF viewer, and use Ctrl+F to search for a drug name.
Why the List Is Hard to Use
Here's the catch: the FDA list doesn't tell you if a drug is still being sold. It only tells you when the manufacturer first reported it in their annual report. That means:
- A drug listed as "entered market on June 11, 2003" might have been discontinued in 2020.
- A drug you see on the list might not be available at your local pharmacy.
- The "date" you see isn't the exact launch date - it's the reporting period. The FDA admits they don't know the real date.
Pharmacists and pharmacy buyers report that 5 out of 8 drugs they check on the list aren't actually available from wholesalers. That's not a mistake - it's how the system works. The FDA doesn't track whether a product is still being made or sold. They only track what manufacturers report once a year.
How to Verify If an Authorized Generic Is Actually Available
If you're a patient, pharmacist, or provider trying to find a low-cost option, don't rely on the FDA list alone. Cross-check with these tools:
- National Drug Code (NDC) Directory - Go to fda.gov/drugs/drug-approvals-and-databases/national-drug-code-directory. Search by drug name or NDC number. If you find an active NDC, it's likely still on the market.
- Commercial databases - Tools like IQVIA National Sales Perspectives track actual sales and distribution. They show which authorized generics are still being shipped to pharmacies.
- Your pharmacy or wholesaler - Ask if they carry the authorized generic version. Many pharmacies know which ones are still active because they order them regularly.
For example, if you see "CLEOCIN T 1% gel" on the FDA list, check the NDC Directory. If it shows an active NDC from Pfizer, then your pharmacy might be able to order it. If not, it's probably discontinued.
Who Uses This List - And Why
The FDA list isn't meant for patients looking for cheap prescriptions. It's meant for:
- Pharmaceutical companies tracking competitors
- Market analysts studying drug pricing trends
- Regulatory agencies like the FTC, which monitor anti-competitive behavior
- Researchers studying how brand manufacturers use authorized generics to delay price drops
A 2023 study found that 854 authorized generics were launched between 2010 and 2019. Pfizer alone had 47 on the list. Teva and Mylan (now Viatris) were also major players. These companies use authorized generics to stay competitive - sometimes even before the first generic hits the market.
But here's the twist: authorized generics often don't save consumers much. A 2020 JAMA study found many authorized generics were priced only slightly lower than the brand name. So while they increase competition, they don't always mean big savings.
What’s Changing in 2026
The FDA has said it plans to replace the PDF list with a searchable, online database by mid-2026. This is a direct response to user feedback. Right now, people have to download a new PDF every quarter and manually search through hundreds of entries. That’s not practical.
The new system will likely include:
- Search by drug name, strength, or manufacturer
- Status indicators (active, discontinued)
- Link to NDC numbers
- More frequent updates
Until then, the PDF remains the only official source. And while it's not perfect, it's still the only place that tells you which brand-name companies have launched their own generics.
Common Mistakes People Make
- Mixing up authorized generics with regular generics - They’re not the same. Regular generics are approved under ANDAs and appear in the Orange Book. Authorized generics are under NDAs and only appear on this list.
- Assuming "entered market" means "currently sold" - It doesn’t. Many entries are years old and no longer available.
- Using the list as a pricing guide - The FDA doesn't track prices. An authorized generic might cost $20, $50, or $100 - it depends on the pharmacy and wholesaler.
Bottom Line
The FDA's authorized generics list is a valuable tool - but only if you understand its limits. It's not a shopping guide. It's not a real-time inventory. It's a historical record of what brand manufacturers have reported. If you're looking for low-cost drugs, use the list to identify possibilities, then verify availability with your pharmacist or the NDC Directory. Don't assume a drug on the list is still available. Always double-check.
For now, the PDF is the only official source. But by mid-2026, that could change. Keep an eye on the FDA's website - a better, searchable tool is coming.
Is the FDA authorized generics list the same as the Orange Book?
No. The Orange Book lists traditional generic drugs approved under Abbreviated New Drug Applications (ANDAs) and includes therapeutic equivalence ratings. Authorized generics are not listed there because they are marketed under the original brand's New Drug Application (NDA), not an ANDA. The FDA's authorized generics list is a separate document that only includes drugs made by the brand manufacturer but sold without the brand name.
Can I use the FDA list to find cheaper drugs at my pharmacy?
You can use it as a starting point, but don't expect every drug on the list to be available. The FDA list doesn't show current market status - only when a product was first reported. Many authorized generics are discontinued or never distributed widely. Always check with your pharmacy or use the National Drug Code Directory to confirm availability.
Why don't authorized generics always cost less than the brand name?
Because they're often priced just below the brand name to maintain profit margins. The brand manufacturer doesn't need to slash prices to compete - they already own the product. Studies show authorized generics sometimes offer only marginal savings, especially compared to traditional generics that come from separate companies competing on price.
How often is the FDA authorized generics list updated?
The list is updated quarterly, as required by law. The most recent version as of October 10, 2025, is the latest available. However, because manufacturers submit annual reports, the data can be up to a year behind. The FDA is planning to replace the PDF with a live database in 2026 to improve timeliness.
Are authorized generics safer or more effective than regular generics?
No. Authorized generics are chemically identical to the brand-name drug - same active ingredient, same dosage, same quality standards. They are considered therapeutically equivalent by the FDA. The only difference is the label. Whether it's made by the brand company or a generic manufacturer, the drug works the same way in your body.
Amrit N
man i just found out about this authorized generics thing last week and i was like wow this could save me like 30 bucks a month on my blood pressure med
took me 20 minutes to find the pdf on the fda site and i still don’t know if mine’s on there or not lol
thanks for the heads up on the ndc directory tho - that’s way easier than scrolling through 800 entries in a pdf
also side note: i typed ‘authorised’ by accident the first time and thought i’d broken the internet
Courtney Hain
let me tell you something that no one else is saying - this whole authorized generics system is a deliberate corporate trap designed by big pharma to trick consumers into thinking they’re getting a deal when they’re really just being sold the same drug with a cheaper label
the fda doesn’t update this list in real time because they’re in cahoots with the manufacturers - think about it: if they made it searchable and real-time, people would realize that 70% of these so-called ‘generics’ have been discontinued for years
and don’t get me started on how teva and pfizer use these to stall actual generic competition - it’s not just market strategy, it’s anti-competitive sabotage
the fact that they’re still using a PDF in 2025? that’s not laziness - that’s obstruction
and yes, i’ve filed a foia request. yes, i’ve emailed the fda. yes, they ignored me. the system is rigged
you think your pharmacy has it? they don’t. they’re told what to order. you think you’re saving money? you’re just paying less to the same company that was charging you more
the 2026 database? don’t believe it. it’ll be gated, slow, and full of disclaimers. mark my words
the real solution? national drug pricing reform. not a better pdf
Robert Shiu
you guys are doing great work breaking this down - seriously, thank you
i’ve been a pharmacy tech for 8 years and i can tell you - this list is a ghost town
we get requests for authorized generics all the time, and 9 out of 10 times, the drug isn’t even available from wholesalers anymore
but here’s the good news: if you know what to look for, you can still find real savings
ask your pharmacist for the ndc number, then call your local wholesaler - they’ll tell you what’s actually in stock
and don’t be shy about asking: ‘is this the same as the brand?’ - most of them will say yes, and then whisper, ‘but we don’t stock it anymore’
you’ve got this. keep asking questions. small wins add up
Greg Scott
nah, i just use goodrx. it tells me what’s cheapest - brand, generic, or whatever.
don’t need the fda pdf.
Scott Dunne
the american healthcare system continues to demonstrate its profound incompetence.
an official government body relies on a quarterly PDF for critical pharmaceutical data - and expects citizens to navigate it manually.
this is not oversight. this is negligence.
in ireland, we have a centralized electronic database updated daily - accessible to all stakeholders, including patients.
the fact that this is still a problem in the united states speaks volumes about systemic failure.
no wonder drug prices are out of control.
Caleb Sciannella
as someone who has spent years working in international pharmaceutical policy, i find this entire situation both fascinating and deeply concerning
the concept of authorized generics was originally intended as a transitional mechanism to ease the market entry of true generics
but what we’ve seen instead is a sophisticated legal maneuver - one that exploits regulatory gaps to delay price erosion
the fda’s lack of real-time tracking is not an accident; it’s a consequence of underfunded oversight
compare this to the european medicines agency, which requires manufacturers to report market status monthly
the fact that the fda still uses a static pdf in 2025 is emblematic of a broader institutional inertia
the upcoming searchable database is a step forward - but it’s still reactive, not proactive
what we need is mandatory, real-time electronic reporting tied to distribution channels
until then, this list remains a historical artifact, not a practical tool
Ashley Paashuis
i appreciate how thorough this post is - especially the breakdown of what the list does and doesn’t show
as someone who helps elderly patients navigate prescriptions, i’ve seen firsthand how confusing this all is
many assume that if it’s on the fda’s website, it’s available - and then get frustrated when their pharmacy says ‘we don’t carry that’
the ndc directory tip is gold - i’m sharing that with my whole team tomorrow
also, thank you for clarifying that authorized generics aren’t safer or more effective - that’s a myth i hear all the time
patients need to know: same drug. same results. just different label
Oana Iordachescu
...this is why i always double-check with my pharmacist - and why i keep a printed copy of the fda list in my binder.
you know what? i even color-coded it.
green = still available (verified via ndc)
red = discontinued (confirmed via wholesale)
yellow = uncertain (waiting on pharmacy call)
yes, i’m that person.
and yes, i’m proud of it.
you’re welcome, future patients.
Davis teo
okay but what if the fda’s list is being manipulated?
i mean - what if they’re hiding drugs that were pulled because they were toxic?
and what if the manufacturers are lying about when they launched them?
and what if the pdf is just a smokescreen to keep us from asking harder questions?
have you ever thought about that?
maybe the real story isn’t about availability - it’s about control
and maybe - just maybe - this whole system is designed to keep us docile
i’ve been researching this for 18 months
and i’m not done yet
Michaela Jorstad
Thank you so much for this detailed breakdown - I really appreciate the clarity.
I’ve been using the FDA list for my work, and I’ve definitely been misled by the ‘entered market’ dates - I assumed they meant ‘currently available.’
But now I’m checking the NDC Directory first - and calling pharmacies directly - and it’s made a huge difference.
Also - the point about authorized generics not always being cheaper? That’s so important.
Patients need to know: just because it’s labeled ‘generic’ doesn’t mean it’s affordable.
Thank you again - this is exactly the kind of info we need.